ERBB2 and neoplasm: Xenograft tumor models have been used to further demonstrate enhanced antitumor activity with combination treatment resulting in tumor regression and inhibition of metastatic tumor spread in host animals, and with confirmation of a loss of cells expressing HER2 as opposed to downregulation of HER2 expression [8].